Search Discussions
View Discussions Replied ToDiscussions Started
cheryl cliff replied Apr 11, 2011 to AVI BioPharma Receives Approval of Nonproprietary Name Eteplirsen for Lead Duchenne Muscular Dystrophy Therapeutic Candidate, AVI-4658
cheryl cliff replied Mar 27, 2011 to clinical trial
cheryl cliff replied Mar 26, 2011 to clinical trial
cheryl cliff replied Mar 26, 2011 to Results of Prosensa’s Extended Phase I/II Exon-skipping Trial in Duchenne Muscular Dystrophy Published in the New England Journal of Medicine
cheryl cliff replied Mar 14, 2011 to My sons deletion
cheryl cliff replied Mar 14, 2011 to SMT C1100 increases utrophin in DMD patient muscle cells to therapeutically beneficial levels
RSS
Welcome toPPMD Community
Sign Upor Sign In
Or sign in with:
Need help using this community site? Visit Ning's Help Page.
Terms of Service
© 2021 Created by PPMD. Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
Please check your browser settings or contact your system administrator.